Professionals 244 Users Online

Endoscopes Market

The increasing prevalence of chronic disorders and growing demands for minimally invasive procedures are expected to drive up the demand for endoscopes in the future

Endoscopes Market Segmentation By Product- ( Rigid Endoscope, Flexible Endoscope, Capsule Endoscope, Robot-assisted Endoscope), The Reusable Endoscope segment is expected to hold the largest market value of US$ 12.1 Billion by 2023.

Endoscope Market Outlook (2023-2033)

Worldwide revenue from the endoscope market was about US$ 13.9 Billion in 2022, with the global market estimated to surge ahead at a CAGR of 6.3% to reach a valuation of US$ 27.3 Billion by the end of 2033.

Endoscope Market Size (2022)

US$ 13.9 Billion

Projected Market Value (2033)

US$ 27.3 Billion

Global Market Growth Rate (2023-2033)

6.3% CAGR

Market Share of Top 5 Countries


As assessed by Persistence Market Research, the reusable endoscope segment is expected to hold the largest market value of US$ 12.1 Billion by 2023. Overall, endoscope market sales account for approximately 3.1% revenue share in the global medical devices market, which was valued at around US$ 456.8 Billion at the end of 2022.

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Sales Analysis of the Global Market from 2015 to 2022 Vs Market Outlook for 2023 to 2033

The global market for endoscopes recorded a historic CAGR of 5.5% in the last 7 years from 2015 to 2022.

Some of the key factors projected to propel market expansion over the forecast years are the rise in the prevalence of chronic conditions and the growing awareness of initial disease diagnosis through minimally invasive procedures. It is also anticipated that favourable reimbursement policies and an increase in the number of endoscopic devices receiving FDA approval would accelerate the market's expansion over time.

  • For instance, the disposable digestive endoscopy system from EndoFresh was given 510(k) clearance by the U.S. FDA in 2021. This equipment was developed to lower the possibility of infections during gastrointestinal treatments.

Functional gastrointestinal disorders are mostly diagnosed and treated through endoscopic procedures. Any area of the gastrointestinal tract, including the stomach, oesophagus, and intestines, can be impacted by functional gastrointestinal disorders. Over the anticipated years, it is projected that the rising prevalence of functional gastrointestinal disorders, such as functional dyspepsia, functional constipation, irritable bowel syndrome (IBS), and diverticulosis will encourage the use of endoscopic equipment and boost the market growth.

  • A study that was published in the journal of Gastroenterology in the year 2021 found that functional gastrointestinal diseases FGIDs affected more than 40% of the world's population.

Unhealthy diets and lifestyles have made obesity a severe health issue that is spreading across the globe. Numerous gastrointestinal conditions, including esophageal adenocarcinoma, erosive esophagitis, gastroesophageal reflux disease, colorectal polyps, and cancer, are linked to it.

  • According to the WHO reports for 2021, more than 1 billion individuals including children and adults worldwide were obese. This number is still rising. According to the WHO, more than 167 million individuals will become overweight or obese by 2025.

The global market is thus likely to show high growth over the coming years at a CAGR of 6.3% and reach a global market size of US$ 27.3 Billion by 2033.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

What Factors Will Drive the Market to Grow Over the Forecast Period?

Increasing Geriatric Population and Increasing Healthcare Spending in Growing Economies”

In endoscopic procedures, diseases are diagnosed and treated through natural body openings and rarely, through a small incision made on the body. In contrast to conventional procedures, which necessitate extensive incisions and increase the likelihood of infection, minimal or no incisions result in a lower risk of infection.

Endoscopic procedures greatly lower healthcare costs. Patients have a shorter hospital stays with cheaper pre- and post-operative costs due to these procedures' short duration and low risk of complications.

Because of these advantages, endoscopic procedures are becoming more widely accepted, which is predicted to increase demand and fuel expansion of the worldwide endoscope market.

The World Health Organization (WHO) reports that life expectancy has risen globally. Age dynamics improved medical and healthcare facilities, and rising lifespans have all contributed to longer life expectancies and, ultimately, growth in the population of elderly people.

Owing to the rising prevalence of gastrointestinal diseases in the elderly population, including bleeding, cancer, and colorectal diseases, the geriatric population has emerged as a prospective target for endoscopic procedures.

Due to the safety and effectiveness of endoscopic procedures, doctors and patients choose various types of endoscopes over conventional procedures for detection and treatment.

In emerging economies, there is a large patient pool for gastrointestinal disease (GI) and cancer. Players have a lot of opportunities because of the rising demand for treatments in these nations. The increase in patient disposable income and the growth of these emerging markets economies will contribute to the market's long-term viability.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Is there any Impact on the Growth of the Global Market?

High Cost of Advanced Devices and Excise Duty Imposed on Manufacturers”

According to a study published in the New England Journal of Medicine in the year 2018, in comparison to conventional laparoscopic surgical procedures, the cost of laparoscopic surgery employing robotic-assisted devices was US$ 1,600 higher.

Due to the high cost of robotic devices, which can vary from US$ 1 million to US$ 2.5 million for each unit, and the high maintenance cost of these systems, robotic-assisted laparoscopic procedures are more expensive than conventional laparoscopic surgeries and open surgical approaches.

Under the Patient Protection and Affordable Care Act (PPACA) of the U.S., a medical device manufacturer is required to pay an additional Medical Device Excise Tax (MDET) of 2.3% on the sale of medical equipment. As a result, on the sale of some medical products, makers and importers are required to pay a certain sum.

Changing regulations to prevent the spread of infection (COVID-19) and supply chain disruption are two other significant challenges that are again limiting the market expansion since the infection is again on the rise. For instance, a 2021 study done by the students from the Cancer Institute of the State of Sao Paulo (ICESP) reported a 55% decrease in endoscopic procedures during the pandemic, with colonoscopy being the most negatively impacted modality.

This factor can prevent the market from expanding during the projected timeframe.

Sales Team

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert
I'm Available

Country-wise Insights

Why is the U.S. Market Booming?

“Rising Prevalence of Gastrointestinal Disorders”

The U.S. is expected to hold around 91.6% market share in the regional endoscope market at the end of 2023.

The U.S. market will continue to hold the top spot during the projected period due to rising acceptance of elective endoscopic operations and increased healthcare spending. Over the course of the forecast period, it is also projected that the increasing prevalence of cancer and associated complications in the U.S. will further propel the market.

For instance, the American Cancer Society estimated that in 2021, there were approximately 1.9 million new cancer cases diagnosed in the U.S.

Will Germany Be a Lucrative Market for the Manufacturers?

“Presence of Key Players”

With an expected market share of about 26.4%, Germany will hold a fair amount of share in the regional market at the end of 2023.

A growing number of patients with functional gastrointestinal disorders and the presence of major players in the market are projected to drive the market for endoscopes to significant growth during the forecast years. The country's market expansion is also predicted to be accelerated by rising demand for minimally invasive endoscopic techniques and improved healthcare infrastructure.

How is China Emerging as a Prominent Market for Endoscope?

“Presence of Large Patient Pool”

China is estimated to hold a market share of about 50.7% of the global endoscope market in 2023.

Gastrointestinal (GI) cancers continue to be a significant public health issue in China, according to a study that was published in the journal Frontiers in Public Health in the year 2022. As per the same study, the most severe GI condition in China has remained stomach cancer. Additionally, the prevalence of cases of stomach, pancreatic, colon, and rectum cancers, as well as the gallbladder and biliary tract malignancies, had increased. It is important to highlight that the prevalence of these conditions in China will help the market grow.

Category-wise Insights

Which Product Segment is Driving Growth of the Global Market?

“Widely Used Therapeutic Option for the Endoscopic Procedures”

The flexible endoscope segment is expected to hold the highest share of around 60.6% of the segment by the end of 2023.

Flexible endoscopes are becoming more and more common among medical professionals as the primary treatment device since they can be performed while under anaesthesia. Flexible endoscopes are used more frequently because of their accessibility, safety, and greater efficiency. Flexible endoscopes are utilized in laparoscopy, arthroscopy, bronchoscopy, and laryngoscopy in addition to other surgical procedures, they are widely utilized, which encourages the segment's expansion.

Why Gastrointestinal (GI) Endoscopy is Widely Adopted in the Global Market?

Increasing Cases of Gastrointestinal Diseases Worldwide”

The gastrointestinal (GI) endoscopy segment is expected to hold the highest share of around 32.3% of the segment by the end of 2023.

The significant share can be linked to the rise in the use of endoscopes for the treatment and diagnosis of gastrointestinal diseases, as well as an increase in the number of upper gastrointestinal procedures performed, which are other major factors contributing to the segment's growth.

How Well the Global Market is Being Driven by the Reusable Endoscope?

“Increasing Focus on Personalized Medications”

The reusable segment is expected to hold a larger share of about 82.1% by the end of 2023.

Reusable endoscopes are reliable and provide patients with appropriate care. These are generally accessible and have FDA clearance for multiple uses and carry out procedures in accordance with the device's authorized purpose. They offer high-quality images, videos, therapeutic solutions, and handling and reprocessing instructions.

Why, in the global endoscope scenario, do patients prefer hospitals the most for diagnosis and treatment?

‘Patients’ Preference for Hospital Care and Treatment’

The hospital segment is expected to hold a larger share of about 62.2% by the end of 2023.

Hospitals are typically considered primary healthcare providers, and the patient population's growing preference for hospitals for the diagnosis and care of chronic diseases, cancer, and gastrointestinal diseases are some of the factors driving the segment's growth. A large number of hospital surgeries, including endoscopic procedures, also promote endoscopy device adoption, promoting segment growth.

Competition Landscape

There are a significant number of manufacturers operating in the worldwide endoscope market, which is a highly fragmented industry. Manufacturers are concentrating on collaborations, partnerships, and mergers to diversify their product offerings and drive sales in various geographies.

Key instances include:

  • In Nov 2021, the FDA granted a 510(k) clearance approval to Medtronic plc's PillCam (Capsule endoscope) for use in remote endoscopic treatments.
  • In April 2021, Ambu Inc. got the approval from Health Canada for the aScope 4 Cysto, an advanced flexible cystoscope platform.

Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the endoscope market, which are available in the full report.

Endoscope Industry Report Scope



Forecast Period


Historical Data Available for


Market Analysis

  • USD Million for Value
  • Units for Volume

Key Countries Covered

  • U.S.
  • Canada
  • Brazil
  • Argentina
  • Mexico
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Russia
  • India
  • Thailand
  • Malaysia
  • Indonesia
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Turkey
  • GCC
  • North Africa
  • South Africa

Key Market Segments Covered

  • Product
  • Application
  • Usability
  • End User
  • Region

Report Coverage

  • Market Forecast
  • Competition Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives

Key Companies’ Profile

  • Medtronic Plc.
  • Olympus Corporation
  • Johnson & Johnson
  • Fujifilm Holdings Corporation
  • Richard Wolf GmbH
  • Braun Melsungen Ag
  • Stryker Corporation
  • PENTAX Medical
  • CONMED Corporation
  • Boston Scientific Corporation
  • Smith & Nephew PLC
  • Ambu Inc.

Customization & Pricing

Available upon Request

Key Segments Covered in Endoscope Industry Research


  • Rigid Endoscope
    • Laparoscopes
    • Cystoscopes
    • Neuroendoscope
    • Bronchoscopes
    • Sigmoidoscopes
    • Laryngoscopes
    • Duodenoscopes
    • Rhinoscopes
    • Arthroscopes
    • Other Rigid Endoscope
  • Flexible Endoscope
    • Upper Gastrointestinal Endoscope
      • Upper Gastrointestinal Videoscopes
      • Upper Gastrointestinal Fiberscopes
    • Colonoscopes
      • Video Colonoscopes
      • Fiber Colonoscopes
    • Bronchoscopes
      • Video Bronchoscopes
      • Fiber Bronchoscopes
    • Sigmoidoscopes
      • Video Sigmoidoscopes
      • Fiber Sigmoidoscopes
    • Laryngoscopes
      • Video Pharyngoscopes
      • Fiber Pharyngoscopes
    • Duodenoscopes
      • Video Duodenoscopes
      • Fiber Duodenoscopes
    • Nasopharyngoscopes
      • Video Nasopharyngoscopes
      • Fiber Nasopharyngoscopes
    • Rhinoscopes
      • Video Rhinoscopes
      • Fiber Rhinoscopes
    • Neuroendoscope
    • Cystoscopes
      • Video Cystoscopes
      • Fiber Cystoscopes
    • Laparoscopes
      • Video Laparoscopes
      • Fiber Laparoscopes
    • Other Flexible Endoscope
  • Capsule Endoscope
    • Colon Capsules
    • Esophageal Capsules
    • Small Bowel Capsules
  • Robot-assisted Endoscope


  • Gastrointestinal (GI) Endoscopy
  • Laparoscopy
  • Arthroscopy
  • Obstetrics/Gynecology Endoscopy
  • Urology Endoscopy (Cytoscopy)
  • ENT Endoscopy
  • Bronchoscopy
  • Mediastinoscopy
  • Others


  • Reusable
  • Disposable

End User:

  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty clinics


  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

- Companies Covered in This Report -

  • Medtronic Plc.
  • Olympus Corporation
  • Johnson & Johnson
  • Fujifilm Holdings Corporation
  • Richard Wolf GmbH
  • Braun Melsungen Ag
  • Stryker Corporation
  • PENTAX Medical
  • CONMED Corporation
  • Boston Scientific Corporation
  • Smith & Nephew PLC

- Frequently Asked Questions -

The global market is anticipated to value at around US$ 14.8 Billion at the end of 2023.

Sales of the market are set to witness growth at a CAGR of 6.3% and be valued at around US$ 27.2 Billion by 2033.

Demand for the market increased at a 5.5% CAGR from 2015 to 2022.

The U.S., China, Japan, Germany, and the U.K. accounted for the major share of the global market as of the year 2022, holding around 58.1% market share.

The U.S. is expected to account for around 91.6% share of the regional market in 2023.

Latin America accounts for around 5.9% share of the global market in 2023.

Japan market is expected to hold a share of about 32.6% in the regional endoscope market in 2023.

Germany is expected to hold about 26.4% of the regional market share at the end of 2023.

The reusable segment is expected to achieve the highest valuation at about US$ 12.1 Billion at the end of 2023.

Arthroscopy segment is expected to experience a significant growth at about 7.6% CAGR over the forecast period.

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate